𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dermatitis after suspected imatinib–levothyroxine interaction in a patient with gastrointestinal stromal tumor

✍ Scribed by Evangelos Cholongitas; Chrysoula Pipili; Konstadinos Katsogridakis; Konstadinos Relos; Maria Dasenaki

Publisher
Springer
Year
2007
Tongue
English
Weight
168 KB
Volume
61
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Resection of residual disease in patient
Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib
✍ Sebastian Bauer; Jörg Thomas Hartmann; Maike de Wit; Hauke Lang; Florian Grabell 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 723 KB

## Abstract Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the gastrointestinal tract. Long‐term survival of patients with metastatic disease has only been observed in patients with completely resected disease. Recently, the tyrosine kinase inhibitor imatinib has b